52% of innovations approved in 2020 have some limitation in their prescription or dispensing El 52% de las innovaciones aprobadas en 2020 tienen alguna limitación a la prescripción o la dispensación Omakase2021-02-10T12:16:21+00:00February 10th, 2021|News & Events| Share This Article LinkedInEmail Related Posts The AEMPS, recognised with the 2021 Public Health Figure award granted by Fundamed & Wecare-u The AEMPS, recognised with the 2021 Public Health Figure award granted by Fundamed & Wecare-u July 9th, 2021 | 0 Comments Revalmed Coordination Group meeting May 2021 Revalmed Coordination Group meeting May 2021 June 25th, 2021 | 0 Comments Updated Annual Report on Orphan Drugs authorised in Spain and approved by the European Commission between 2003 & 2020 Updated Annual Report on Orphan Drugs authorised in Spain and approved by the European Commission between 2003 & 2020 April 9th, 2021 | 0 Comments Alicia Gil, miembro de SWL Alicia Gil, miembro de SWL March 26th, 2021 | 0 Comments The Omakase community grows to 1000 followers! The Omakase community grows to 1000 followers! March 16th, 2021 | 0 Comments Dr Poveda and Dr Badia tell us how to use the Orphan Drugs Horizon Scanning report in Spain Dr Poveda and Dr Badia tell us how to use the Orphan Drugs Horizon Scanning report in Spain February 26th, 2021 | 0 Comments We are proud to announce the release of Horizon Scanning 2020 where Omakase Consulting is working with Orphar-SEFH We are proud to announce the release of Horizon Scanning 2020 where Omakase Consulting is working with Orphar-SEFH February 23rd, 2021 | 0 Comments CHMP positive opinions January 2021 CHMP positive opinions January 2021 February 2nd, 2021 | 0 Comments Leave A Comment Cancel reply Comment Save my name, email, and website in this browser for the next time I comment.
Leave A Comment